Namitha Rao

Namitha Rao has a strong background in regulatory affairs, with experience in various roles and companies. Namitha is currently the Director of Regulatory Affairs Strategy at Pliant Therapeutics, a position they have held since March 2023. Prior to that, they worked as the Director of Regulatory Affairs at Eiger BioPharmaceuticals from July 2022 to March 2023, and as the Director of Regulatory Affairs at Sierra Oncology from April 2022 to July 2022.

Before transitioning into regulatory affairs, Namitha worked at Protagonist Therapeutics from 2015 to 2022, holding roles such as Senior Manager/Manager of Regulatory Affairs and Regulatory Affairs Specialist III. Namitha started their career as a Staff Scientist at Protagonist Therapeutics from September 2015 to 2017, where they successfully set up a Flow Cytometry lab and worked on generating important PD data for clinical trials.

Prior to Protagonist Therapeutics, Namitha worked as a Senior Research Associate at Aragen Bioscience from February 2011 to September 2015, at Geron Corporation from February 2006 to October 2008, and at Celliance from 2003 to 2006.

Overall, Namitha Rao has a diverse and extensive work experience in regulatory affairs, research, and scientific roles, making their well-suited for their current position at Pliant Therapeutics.

Namitha Rao completed a Master of Science degree in Regulatory Affairs from Regulatory Affairs Online (RAPS Online) in 2018. Prior to that, there is no information available about their education. Namitha also obtained a certification in the Becton Dickson (BD) FACS Course from BD Biosciences in November 2015.